David L Askelson, PAC in Clarence, IA - Physician Assistant

David L Askelson, PAC is a Physician Assistant based in Clarence, Iowa. David L Askelson is licensed to practice in Iowa (license number 000637) and his current practice location is 411 1st Ave, Clarence, Iowa. He can be reached at his office (for appointments etc.) via phone at (563) 452-3211.

NPI number for David L Askelson is 1912983966 and his current mailing address is 411 1st Ave, Clarence, Iowa. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1912983966.

Contact Information

	David L Askelson, PAC
	411 1st Ave, Clarence, IA 52216-9744
	(563) 452-3211
	(563) 452-3215

Provider's Profile

Full Name	David L Askelson
Gender	Male
Speciality	Physician Assistant
Location	411 1st Ave, Clarence, Iowa
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1912983966
Provider Enumeration Date: 12/21/2005
Last Update Date: 05/22/2008

Medical Identifiers

Medical identifiers for David L Askelson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1912983966	NPI	-	NPPES
970011410	Other	IA	RR MEDICARE
970011402	Other	IA	RR MEDICARE
970011412	Other	IA	RR MEDICARE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363A00000X	Physician Assistant	000637 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David L Askelson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
David L Askelson, PAC 411 1st Ave, Clarence, IA 52216-9744 Ph: (563) 452-3211	David L Askelson, PAC 411 1st Ave, Clarence, IA 52216-9744 Ph: (563) 452-3211

News Archive

HBV-infected men more likely to develop liver cancer

A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer.

OGT launches Cytocell FISH probes for glial tumours

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for the reliable investigation of glial tumours.

Exercise re-ignites key areas of the brain

Too old to learn new skills? By golly, think again. New research at the University of Illinois at Urbana-Champaign shows that training re-ignites key areas of the brain, offsetting some age-related declines and boosting performance.

New $2.8 million NIH grant to help researchers find better treatments for hemorrhagic strokes

Developing better treatments and an improved understanding of the biology behind brain injury from hemorrhagic strokes is the main goal of a three-year $2.8 million grant to the Translational Genomics Research Institute, Phoenix Children's Hospital, and Barrow Neurological Institute.

Scientists explore ways for drug therapies to reach deadly brain tumors

The blood-brain barrier is a specialized network of vascular and brain cells that acts as the brain's security system, helping to safeguard the brain and regulate the flow of substances into and out of it.

David L Askelson, PAC - Physician Assistant in Clarence, IA